With headsets for gamers, scientists can use open-source software to create 3D research environments
- UC Davis signs agreement to license novel CT scanning technology: May, 2017 - UC Davis Health System research news
SACRAMENTO, Calif. (May 24, 2017) - UC Davis has signed a licensing agreement providing Isotropic Imaging Corporation the rights to commercialize a novel computed tomography (CT) scanner that has the potential to improve breast cancer detection and positively impact women’s health.
- UC Davis Duchenne team honored by national parent organization: May, 2017 - UC Davis Health System research news
SACRAMENTO, Calif. (May 5, 2017) - The UC Davis Neuromuscular Research Center has been recognized as a Certified Duchenne Care Center by Parent Project Muscular Dystrophy for national leadership in treating Duchenne muscular dystrophy.
- Less is best when treating burn patients with blood transfusions: April, 2017 - UC Davis Health System research news
SACRAMENTO, Calif. (April 26, 2017) - Reducing by half the typical amount of blood provided through transfusions to burn patients makes no difference in terms of patient outcomes, a new multi-center study led by UC Davis researchers shows.
- Early cancer deaths linked to being single, living in a poor neighborhood: April, 2017 - UC Davis Health System research news
SACRAMENTO, Calif. (April 25, 2017) - Patients in California hospitals were more likely to die within 60 days of being diagnosed with acute myeloid leukemia – a cancer of the blood and bone marrow – if they were unmarried, lived in a less-affluent neighborhood or lacked health insurance. The UC Davis study also found that patients treated at a National Cancer Institute (NCI)-designated cancer center were more likely to survive.
- Second cancers deadlier in young patients: April, 2017 - UC Davis Health System research news
SACRAMENTO, Calif. (April 20, 2017) - Second cancers in children and adolescents and young adults (AYA) are far deadlier than they are in older adults and may partially account for the relatively poor outcomes of cancer patients ages 15-39 overall, a new study by UC Davis researchers has found.
- Improving outcomes for adults with autism spectrum disorder: April, 2017 - UC Davis Health System research news
SACRAMENTO, Calif. (April 7, 2017) - Adults with autism spectrum disorder (ASD) will be the topic of the next Minds behind the MIND lecture on April 19 at 5:30 p.m. at the UC Davis MIND Institute, 2825 50th St. in Sacramento. The lecture is free and open to the public.
- Hitting cancer with high-intensity ultrasound and immunotherapy: March, 2017 - UC Davis Health System research news
SACRAMENTO, Calif. (March 23, 2017) - In a new study published today in JCI Insight, UC Davis researchers have shown that combining high-intensity focused ultrasound with two immunotherapies (a PD-1 checkpoint inhibitor and TLR9 agonist) can produce excellent response rates in mouse models of epithelial cancer. They also found that, for the combination to be effective, immunotherapies must come first.
- UC Davis researchers investigate adult blood-clotting drug for use in severely injured children: March, 2017 - UC Davis Health System research news
SACRAMENTO, Calif. (March 14, 2017) - UC Davis emergency medicine researchers have been awarded a grant from the National Institutes of Health (National Heart, Lung, and Blood Institute) to investigate the safety and efficacy of a drug known to stop bleeding in injured adults for use in cases of pediatric trauma.
- How H. pylori thrives in the highly acidic stomach: March, 2017 - UC Davis Health System research news
SACRAMENTO, Calif. (March 9, 2017) - An international team of reseachers led by Thomas Borén at Umeå University and including Jay Solnick, professor internal medicine at UC Davis, has discovered the tmechanism that gives the bacteria such staying-power and ability to cause chronic infection.
- Developing new collaborations and technologies: March, 2017 - UC Davis Health System research news
SACRAMENTO, Calif. (March 7, 2017) - With a $1 million grant from the National Science Foundation (NSF), UC Davis and Boston University will focus on establishing partnerships with industry, academe and government that lead to the development of innovative biophotonic technologies for use in medicine and other scientific disciplines.